Leucine

Leucine

SCHEMBL6534720

CC(C)C[C@H](N)C(=O)O.C[C@H](N)C(=O)O.NCC(=O)O.NCC(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Leucine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.46
SLC1A3 P43003 3/20 0.39
SLC1A2 P43004 3/20 0.39
SLC1A1 P43005 2/20 0.34
DPP4 P27487 3/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
REN P00797 1/20 0.32
PRCP P42785 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leucine SCHEMBL28334400 1.00 SLC7A5 (0.46) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL7110075 1.00 SLC7A5 (0.46) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL4612424 0.97 SLC7A5 (0.49) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL21382169 0.97 SLC7A5 (0.49) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL28392735 0.97 SLC7A5 (0.49) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL23091356 0.97 SLC7A5 (0.49) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL3089172 0.97 SLC7A5 (0.49) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL1675456 0.97 SLC7A5 (0.49) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL5889661 0.97 SLC7A5 (0.49) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Leucine SCHEMBL27683459 0.97 SLC7A5 (0.49) SLC7A5SLC1A3SLC1A2SLC1A1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064010-A4 PEPTIDE COMPOSITIONS AND FORMULATIONS AND USE OF SAME CONNECTIVE TISSUE IMAGINEERING (US) 2004-10-06 EP claimed
EP-1064010-A1 PEPTIDE COMPOSITIONS AND FORMULATIONS AND USE OF SAME Mrs, Llc (US) 2001-01-03 EP claimed
WO-1999045941-A1 PEPTIDE COMPOSITIONS AND FORMULATIONS AND USE OF SAME MRS, LLC (US) 1999-09-16 WO claimed